NCT03534180 2023-10-19
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
City of Hope Medical Center
Phase 2 Completed
Clinical Trials
3 trialsNCT00085527 2013-09-05
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
University of Chicago
Phase 2 Withdrawn
NCT00299351 2006-03-06
A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.
Royal Marsden NHS Foundation Trust
Phase 2 Unknown